Literature DB >> 15541643

Effects of MAPK inhibitors on CCR4-mediated chemotaxis against thymus and activation-regulated chemokine (TARC/CCL17).

Yoichi Moroi, Bin Yu, Kazunori Urabe, Tetsuya Koga, Takeshi Nakahara, Teruki Dainichi, Hiroshi Uchi, Masutaka Furue.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15541643     DOI： 10.1016/j.jdermsci.2004.08.013

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  3 in total

1.  Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.

Authors:  Sandra Santulli-Marotto; Ken Boakye; Eilyn Lacy; Sheng-Jiun Wu; Jennifer Luongo; Karl Kavalkovich; Ana Coelho; Cory M Hogaboam; Mary Ryan
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

2.  Role of ERK Pathway in the Pathogenesis of Atopic Dermatitis and Its Potential as a Therapeutic Target.

Authors:  Nahoko Zeze; Makiko Kido-Nakahara; Gaku Tsuji; Eriko Maehara; Yuki Sato; Sawako Sakai; Kei Fujishima; Akiko Hashimoto-Hachiya; Masutaka Furue; Takeshi Nakahara
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

3.  CCL17/TARC and CCR4 expression in Merkel cell carcinoma.

Authors:  Kashif Rasheed; Ibrahim Abdulsalam; Silje Fismen; Øystein Grimstad; Baldur Sveinbjørnsson; Ugo Moens
Journal:  Oncotarget       Date:  2018-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.